Blog
Why CGT 3.0 success depends on interoperability
Blog
The cutting edge therapies of CGT 3.0 require modern operations. That means far more than just stand-alone digital systems and select integrations — it means…
How integrated digital systems solve key challenges with cell and gene therapies (CGTs)
Blog
One patient. One cell therapy. Ten or more distinct digital systems.
That’s often the number of heterogeneous digital systems across care sites, manufacturers, and…
Be The Match BioTherapies® and Vineti collaborate to develop innovative, integrated supply chain management solutions for cell and gene therapies
Blog
MINNEAPOLIS, Minn. and SAN FRANCISCO, Calif, December 08, 2021 - Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and…